Cargando…
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779080/ https://www.ncbi.nlm.nih.gov/pubmed/33392703 http://dx.doi.org/10.1007/s00277-020-04388-6 |
| _version_ | 1783631259693481984 |
|---|---|
| author | Yamasaki, Satoshi Matsushima, Takumi Minami, Mariko Kadowaki, Masanori Takase, Ken Iwasaki, Hiromi |
| author_facet | Yamasaki, Satoshi Matsushima, Takumi Minami, Mariko Kadowaki, Masanori Takase, Ken Iwasaki, Hiromi |
| author_sort | Yamasaki, Satoshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7779080 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77790802021-01-04 Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study Yamasaki, Satoshi Matsushima, Takumi Minami, Mariko Kadowaki, Masanori Takase, Ken Iwasaki, Hiromi Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2021-01-03 2022 /pmc/articles/PMC7779080/ /pubmed/33392703 http://dx.doi.org/10.1007/s00277-020-04388-6 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Yamasaki, Satoshi Matsushima, Takumi Minami, Mariko Kadowaki, Masanori Takase, Ken Iwasaki, Hiromi Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title | Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title_full | Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title_fullStr | Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title_full_unstemmed | Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title_short | Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| title_sort | clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779080/ https://www.ncbi.nlm.nih.gov/pubmed/33392703 http://dx.doi.org/10.1007/s00277-020-04388-6 |
| work_keys_str_mv | AT yamasakisatoshi clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy AT matsushimatakumi clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy AT minamimariko clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy AT kadowakimasanori clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy AT takaseken clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy AT iwasakihiromi clinicalimpactofbendamustineexposureonlymphopeniariskafterbendamustineandrituximabcombinationtherapyforfollicularlymphomaasingleinstituteretrospectivestudy |